insights_auto
Why is DNA down 5.97%?
Dive Deeperchevron_right
DNA:NYSE
Ginkgo Bioworks Holdings Inc
$9.61
arrow_downward
-5.97%(-0.61) 1D
$9.75
arrow_upward
+1.46% (+0.14)bedtimeAfter hours
Closed: Nov 13, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
$10.00
High
$10.05
Low
$9.39
Mkt. cap
594.14M
Avg. vol.
3.23M
Volume
1.86M
52-wk high
$18.22
52-wk low
$5.37
EPS
-$4.19
Beta
1.74
Shares outstanding
55.38M
No. of employees
485
Open
$10.00
High
$10.05
Low
$9.39
Mkt. cap
594.14M
Avg. vol.
3.23M
Volume
1.86M
52-wk high
$18.22
52-wk low
$5.37
EPS
-$4.19
Beta
1.74
Shares outstanding
55.38M
No. of employees
485
News stories
From web sources and news partners
ING Sprinters
·
2 days ago
De AEX Index blijft voortmodderen
Nieuws.nl
·
1 day ago
AEX-index lager door onrust rond Nvidia
Trefis
·
57 minutes ago
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees485
Founded2008
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
Industry-
Websiteginkgo.bio